Skip to main content
. 2020 Jul 6;15(2):232–242. doi: 10.5009/gnl19433

Fig. 3.

Fig. 3

Kaplan-Meier curve of cumulative outcomes based on baseline C-reactive protein (CRP) levels in patients with ulcerative colitis treated with tumor necrosis factor (TNF)-α inhibitors (1-rate of poor outcome event). *Poor outcomes are defined as the sum of the following events: all-cause hospitalization, ulcerative colitis-related hospitalization, corticosteroid prescription, discontinuation of TNF-α inhibitors, and switching to a secondary TNF-α inhibitor.